Global Albumin (as Excipient) Supply, Demand and Key Producers, 2026-2032
Description
The global Albumin (as Excipient) market size is expected to reach $ 2650 million by 2032, rising at a market growth of 6.3% CAGR during the forecast period (2026-2032).
Albumin excipients refer to human serum albumin (HSA) or recombinant human serum albumin (rHSA) used as excipients in biopharmaceuticals. Their primary functions include stabilizing the structure and activity of protein drugs, enhancing drug solubility and bioavailability as carriers, and serving as nutritional components in vaccines and cell culture media. With the advancement of biologics and vaccine development, the application of albumin excipients in drug formulations is becoming increasingly widespread.In 2024, global Albumin (as Excipient) production reached approximately 440 mt, with an average global market price of around US$ 3622 per kg.
The albumin excipient market is experiencing unprecedented growth opportunities due to the global rise in chronic diseases, rapid expansion of the biopharmaceutical industry, and increasing demand for efficient drug delivery systems. Particularly in vaccine development and gene therapy, albumin excipients have become indispensable components due to their excellent biocompatibility and stability. Furthermore, advancements in recombinant albumin technologies have made the production process safer and more controllable, further driving market growth.
Despite the promising prospects, the albumin excipient market faces several challenges. Firstly, the source and quality control of raw materials are critical, especially the supply of human-derived albumin, which may affect production stability. Secondly, stringent regulatory requirements and quality standards make the research and development process complex and time-consuming. Additionally, increasing market competition from emerging enterprises and technologies may threaten the market share of existing companies.
Downstream demand is primarily concentrated in areas such as vaccines, cell culture media, protein drugs, and gene therapies. With the rise of personalized medicine and precision therapy, the demand for high-quality excipients continues to increase. Moreover, the growing aging population globally is driving the demand for chronic disease treatment drugs, thereby boosting the need for albumin excipients.
The main raw materials for albumin excipients include human serum albumin and recombinant bovine serum albumin. Human serum albumin is primarily sourced from plasma collection; however, its supply is limited by the number of blood donors and ethical issues related to plasma collection. On the other hand, recombinant bovine serum albumin production relies on bioreactor technology, which has higher production costs and technical requirements. Therefore, the stable supply and cost control of raw materials are key factors influencing the development of the albumin excipient market.
This report studies the global Albumin (as Excipient) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Albumin (as Excipient) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Albumin (as Excipient) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Albumin (as Excipient) total production and demand, 2021-2032, (MT)
Global Albumin (as Excipient) total production value, 2021-2032, (USD Million)
Global Albumin (as Excipient) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Albumin (as Excipient) consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Albumin (as Excipient) domestic production, consumption, key domestic manufacturers and share
Global Albumin (as Excipient) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Albumin (as Excipient) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Albumin (as Excipient) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Albumin (as Excipient) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Tiantan Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Albumin (as Excipient) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Albumin (as Excipient) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Albumin (as Excipient) Market, Segmentation by Type:
20-25% Concentrations
5% Concentrations
Global Albumin (as Excipient) Market, Segmentation by Application:
Cell Culture Media
Medical Excipient
Companies Profiled:
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Key Questions Answered:
1. How big is the global Albumin (as Excipient) market?
2. What is the demand of the global Albumin (as Excipient) market?
3. What is the year over year growth of the global Albumin (as Excipient) market?
4. What is the production and production value of the global Albumin (as Excipient) market?
5. Who are the key producers in the global Albumin (as Excipient) market?
6. What are the growth factors driving the market demand?
Albumin excipients refer to human serum albumin (HSA) or recombinant human serum albumin (rHSA) used as excipients in biopharmaceuticals. Their primary functions include stabilizing the structure and activity of protein drugs, enhancing drug solubility and bioavailability as carriers, and serving as nutritional components in vaccines and cell culture media. With the advancement of biologics and vaccine development, the application of albumin excipients in drug formulations is becoming increasingly widespread.In 2024, global Albumin (as Excipient) production reached approximately 440 mt, with an average global market price of around US$ 3622 per kg.
The albumin excipient market is experiencing unprecedented growth opportunities due to the global rise in chronic diseases, rapid expansion of the biopharmaceutical industry, and increasing demand for efficient drug delivery systems. Particularly in vaccine development and gene therapy, albumin excipients have become indispensable components due to their excellent biocompatibility and stability. Furthermore, advancements in recombinant albumin technologies have made the production process safer and more controllable, further driving market growth.
Despite the promising prospects, the albumin excipient market faces several challenges. Firstly, the source and quality control of raw materials are critical, especially the supply of human-derived albumin, which may affect production stability. Secondly, stringent regulatory requirements and quality standards make the research and development process complex and time-consuming. Additionally, increasing market competition from emerging enterprises and technologies may threaten the market share of existing companies.
Downstream demand is primarily concentrated in areas such as vaccines, cell culture media, protein drugs, and gene therapies. With the rise of personalized medicine and precision therapy, the demand for high-quality excipients continues to increase. Moreover, the growing aging population globally is driving the demand for chronic disease treatment drugs, thereby boosting the need for albumin excipients.
The main raw materials for albumin excipients include human serum albumin and recombinant bovine serum albumin. Human serum albumin is primarily sourced from plasma collection; however, its supply is limited by the number of blood donors and ethical issues related to plasma collection. On the other hand, recombinant bovine serum albumin production relies on bioreactor technology, which has higher production costs and technical requirements. Therefore, the stable supply and cost control of raw materials are key factors influencing the development of the albumin excipient market.
This report studies the global Albumin (as Excipient) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Albumin (as Excipient) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Albumin (as Excipient) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Albumin (as Excipient) total production and demand, 2021-2032, (MT)
Global Albumin (as Excipient) total production value, 2021-2032, (USD Million)
Global Albumin (as Excipient) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Albumin (as Excipient) consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Albumin (as Excipient) domestic production, consumption, key domestic manufacturers and share
Global Albumin (as Excipient) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Albumin (as Excipient) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Albumin (as Excipient) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Albumin (as Excipient) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Tiantan Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Albumin (as Excipient) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Albumin (as Excipient) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Albumin (as Excipient) Market, Segmentation by Type:
20-25% Concentrations
5% Concentrations
Global Albumin (as Excipient) Market, Segmentation by Application:
Cell Culture Media
Medical Excipient
Companies Profiled:
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Key Questions Answered:
1. How big is the global Albumin (as Excipient) market?
2. What is the demand of the global Albumin (as Excipient) market?
3. What is the year over year growth of the global Albumin (as Excipient) market?
4. What is the production and production value of the global Albumin (as Excipient) market?
5. Who are the key producers in the global Albumin (as Excipient) market?
6. What are the growth factors driving the market demand?
Table of Contents
128 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
